Trials / Active Not Recruiting
Active Not RecruitingNCT04337710
Exclusive Enteral Nutrition in Preterm Neonates
Exclusive Enteral Nutrition in Preterm Neonates- A Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 1 Hour – 48 Hours
- Healthy volunteers
- Not accepted
Summary
To test the hypothesis that early exclusive enteral nutrition with the minimal use of parenteral nutrition will improve preterm infants' nutritional outcomes when compared to delayed progression of enteral nutrition and prolonged use of parenteral nutrition.
Detailed description
Qualifying participants will be randomly assigned to one of two study groups: 1) Exclusive Enteral Feeds or 2) Progressive Enteral Feeds with supplemental parenteral nutrition. Regardless of study group assignment, donor human milk will be offered if the mother's expressed breast milk is not enough to complete the intervention as assigned. Intervention group: Feeds will be initiated with a target volume of 60-80 ml/kg/day and then advanced by 20-30 ml/kg/day until the total volume of 150ml/kg/day is achieved. Control group: Enteral feeds will be initiated with a target volume of 20-30 ml/kg/day and then advanced by 20-30 ml/kg/day until the total volume of 150 ml/kg/day is achieved. If parent agrees, stool "dirty" diapers will be collected 2 times during this study. One time around the time of birth and one time at 28 days or discharge (whichever occurs first).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Exclusive Enteral Nutrition | Mom's milk or donor milk at 60-80 ml/kg/day after randomization within the first 24 hours. |
| PROCEDURE | Progressive Enteral Nutrition | Mom's milk or donor milk at 20-30 ml/kg/day after randomization within the first 24 hours. |
Timeline
- Start date
- 2021-05-27
- Primary completion
- 2022-09-12
- Completion
- 2026-05-01
- First posted
- 2020-04-08
- Last updated
- 2025-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04337710. Inclusion in this directory is not an endorsement.